Oxytocic Pharmaceuticals Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2015 to 2020 and Forecast 2021 to 2027

$ PRICE - $ 3,000.00$ 8,900.00

Oxytocic Pharmaceuticals Market: By Product Type (Intramuscular Injection, Intravenous Injection), By Source (Natural Oxytocin (Animal Pituitary Extracts), Synthetic Oxytocin), By End-User (Maternity Clinics, Hospitals), and Geography 

 

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail

Report

Description

The Global Oxytocic Pharmaceuticals Market size was estimated at USD 196.6 Mn in 2021, growing at a CAGR of 7.2% during the forecast period 2021-2027. Oxytocin is a female reproductive hormone secreted in the hypothalamus and released into blood circulation during childbirth to induce the labor and milk production in mothers. It is also used as uterotonic (induce uterine contractions) and reduce the hemorrhage after C-section. Increase in the number of preterm births, rise in labor induction rates, escalation in complicated pregnancy cases in developing countries, and increase in awareness about maternal health are anticipated to propel the oxytocic pharmaceuticals market. However, adverse effects associated with oxytocic drugs may restrain the growth of oxytocic drugs market over the forecast period. Industry trends in the market are evolving, which will aid players in developing successful long-term strategies. Both established and emerging markets have implemented business growth techniques. COVID-19 is an unprecedented worldwide public health crisis that has impacted practically every business, and its long-term repercussions are expected to have an influence on industry growth during the projection period. Our continuous study is enhancing our research approach to guarantee that fundamental COVID-19 concerns and potential solutions are included. The research examines COVID-19 in light of changes in consumer behaviour and demand, purchasing patterns, supply chain re-routing, market dynamics, and government involvement. The revised report considers the influence of COVID-19 on the market and includes insights, analysis, projections, and predictions.


Oxytocic Pharmaceuticals Market

MARKET SUMMARY
-
7.2% CAGR
  • Study Period– 2021 – 2027
  • Base Year– 2020
  • CAGR– 7.2%
  • Largest Market– North America
  • Fastest Growing Market– Europe

Oxytocic Pharmaceuticals Market

  • The report on the global oxytocic pharmaceuticals market gives historical, current, and future market sizes (US$ Mn) on the basis of product type, source, end user, and regions.
  • Global oxytocic pharmaceuticals market gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
Market Key Players
  • Pfizer, Inc. (U.S.)
  • Fresenius Kabi AG (Germany)
  • Novartis AG (Switzerland)
  • Cardinal Health (U.S.)
  • Ferring Pharmaceuticals B.V. (Switzerland)
  • Par Pharmaceutical, Inc. (U.S.)
Drivers And Restraints

Oxytocic Pharmaceuticals Market

The worldwide oxytocic pharmaceuticals industry is projected to be hampered by the availability of alternative medications. Misoprostol and magnesium sulphates are two oxytocic medicinal options. Misoprostol is a low-cost, evidence-based alternative to oxytocin, according to the World Health Organization.


North-America got significant share

Oxytocic Pharmaceuticals Market

Geographically, global oxytocic pharmaceuticals market segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa regions. North America oxytocic pharmaceuticals market is growing due to rise in incidence of induced labor, high awareness about oxytocic drugs, and rise in awareness about maternal health. Europe oxytocic pharmaceuticals market has a lucrative growth, which is attributed to presence of huge number of companies manufacturing the oxytocin drugs and rise in oxytocin usage during labor in the region. Asia Pacific oxytocic pharmaceuticals market is poised to grow at significant rate due to rise in childbirths in India and China, increase in female population, and rise in awareness about oxytocic drugs among healthcare professionals. Latin America oxytocic pharmaceuticals market has a notable share owing to increase in adolescent pregnancies in Brazil and rise in labor induction procedures. Middle East and Africa oxytocic pharmaceuticals market growth driven by higher prevalence of post-partum hemorrhage due to lack of nutrition in pregnant women and rise in awareness about pregnancy-related issues among healthcare professionals.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Key Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market and forecast.
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Segmentation

Oxytocic Pharmaceuticals Market


Location

GEOGRAPHY


Report

Table Of Content


Report

Company Profile

  • Pfizer, Inc. (U.S.)
  • Fresenius Kabi AG (Germany)
  • Novartis AG (Switzerland)
  • Cardinal Health (U.S.)
  • Par Pharmaceutical, Inc. (U.S.)

Description

The Global Oxytocic Pharmaceuticals Market size was estimated at USD 196.6 Mn in 2021, growing at a CAGR of 7.2% during the forecast period 2021-2027. Oxytocin is a female reproductive hormone secreted in the hypothalamus and released into blood circulation during childbirth to induce the labor and milk production in mothers. It is also used as uterotonic (induce uterine contractions) and reduce the hemorrhage after C-section. Increase in the number of preterm births, rise in labor induction rates, escalation in complicated pregnancy cases in developing countries, and increase in awareness about maternal health are anticipated to propel the oxytocic pharmaceuticals market. However, adverse effects associated with oxytocic drugs may restrain the growth of oxytocic drugs market over the forecast period. Industry trends in the market are evolving, which will aid players in developing successful long-term strategies. Both established and emerging markets have implemented business growth techniques. COVID-19 is an unprecedented worldwide public health crisis that has impacted practically every business, and its long-term repercussions are expected to have an influence on industry growth during the projection period. Our continuous study is enhancing our research approach to guarantee that fundamental COVID-19 concerns and potential solutions are included. The research examines COVID-19 in light of changes in consumer behaviour and demand, purchasing patterns, supply chain re-routing, market dynamics, and government involvement. The revised report considers the influence of COVID-19 on the market and includes insights, analysis, projections, and predictions.

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX